Genetic ablation of CypA in ApoE KO mice has been shown to be anti-atherogenic [39], whereas pharmacological inhibition of CypA in ApoE KO mice promotes atherosclerosis [40]. The gene discussed is APOE; the disease is atherosclerosis.